Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is $19.17.

A number of brokerages have recently commented on CCAP. LADENBURG THALM/SH SH began coverage on shares of Crescent Capital BDC in a research report on Monday, September 30th. They issued a “buy” rating and a $20.00 price objective on the stock. Bank of America dropped their price target on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, August 15th. Wells Fargo & Company dropped their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 14th. Finally, Keefe, Bruyette & Woods upped their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday.

Read Our Latest Stock Analysis on CCAP

Institutional Trading of Crescent Capital BDC

Hedge funds and other institutional investors have recently bought and sold shares of the business. Point72 Asset Management L.P. acquired a new stake in Crescent Capital BDC in the 2nd quarter worth about $90,000. XTX Topco Ltd bought a new position in Crescent Capital BDC in the 2nd quarter valued at about $195,000. Alpine Global Management LLC bought a new position in Crescent Capital BDC in the 1st quarter valued at about $217,000. Catalina Capital Group LLC bought a new position in Crescent Capital BDC in the 2nd quarter valued at about $220,000. Finally, Cubist Systematic Strategies LLC bought a new position in Crescent Capital BDC in the 2nd quarter valued at about $346,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Stock Down 0.2 %

Crescent Capital BDC stock opened at $19.18 on Tuesday. The company has a 50 day moving average of $18.55 and a 200-day moving average of $18.50. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. The stock has a market capitalization of $710.81 million, a PE ratio of 7.52 and a beta of 0.81. Crescent Capital BDC has a twelve month low of $15.91 and a twelve month high of $19.63.

Crescent Capital BDC Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.76%. The ex-dividend date of this dividend is Tuesday, December 31st. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 65.88%.

About Crescent Capital BDC

(Get Free Report

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.